Aristarchos Papagiannaros
Overview
Explore the profile of Aristarchos Papagiannaros including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papagiannaros A, Righi V, Day G, Rahme L, Liu P, Fischman A, et al.
Adv J Mol Imaging
. 2014 Jul;
2(4):31-37.
PMID: 24995147
MR imaging of gene transcription is important as it should enable the non-invasive detection of mRNA alterations in disease. A range of MRI methods have been proposed for molecular imaging...
2.
Papagiannaros A, Upponi J, Hartner W, Mongayt D, Levchenko T, Torchilin V
BMC Med Imaging
. 2010 Oct;
10:22.
PMID: 20955559
Background: Optical imaging is a promising method for the detection of tumors in animals, with speed and minimal invasiveness. We have previously developed a lipid coated quantum dot system that...
3.
Papagiannaros A, Kale A, Levchenko T, Mongayt D, Hartner W, Torchilin V
Int J Nanomedicine
. 2009 Jun;
4:123-31.
PMID: 19516891
A novel highly biocompatible near infrared nanosized contrast agent was developed and used for rapid tumor detection and quantification using planar optical imaging and analysis. With this in mind, the...
4.
Papagiannaros A, Levchenko T, Hartner W, Mongayt D, Torchilin V
Nanomedicine
. 2009 Feb;
5(2):216-24.
PMID: 19223245
Near-infrared (NIR) whole-body imaging is a powerful noninvasive method for the visualization of complex biological phenomena such as tumor and tumor vasculature and for whole-body studies. In this study we...
5.
Papagiannaros A, Hatziantoniou S, Dimas K, Papaioannou G, Demetzos C
Biomed Pharmacother
. 2005 Nov;
60(1):36-42.
PMID: 16271845
The overall goal of this study was to prepare a novel liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC), as a combined formulation and to study its activity against cancer...
6.
Papagiannaros A, Dimas K, Papaioannou G, Demetzos C
Int J Pharm
. 2005 Aug;
302(1-2):29-38.
PMID: 16099117
Liposomes composed of HePC:EPC:SA 10:10:0.1 (molar ratio) (1) and EPC:SA 10:0.1 (molar ratio) (2) were prepared and were used for incorporating the doxorubicin-PAMAM complex (3:1 molar ratio) (3). The doxorubicin-PAMAM...